首页> 外文OA文献 >A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008–2013)

【2h】

A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008–2013)

机译：长期立即释放氢可酮/对乙酰氨基酚的使用和对乙酰氨基酚的剂量超过食品和药物管理局建议的每日回顾性队列研究，在美国，有商业保险的个人的最大每日限量（2008-2013年）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
DeVeaugh-Geiss Angela; Kadakia Aditi; Chilcoat Howard; Alexander Louis; Coplan Paul;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008-2013) [J] . DeVeaugh-Geiss Angela, Kadakia Aditi, Chilcoat Howard, The journal of pain: official journal of the American Pain Society . 2015,第6期

机译：长期立即释放氢可酮/对乙酰氨基酚的使用和对乙酰氨基酚的剂量超过食品和药物管理局建议的每日回顾性队列研究，建议美国商业参保人员的最大每日限量（2008-2013年）
2. Five‐year trends in acetaminophen use exceeding the recommended daily maximum dose [J] . Kaufman David W., Kelly Judith P., Battista Deena R., British Journal of Clinical Pharmacology . 2019,第5期

机译：乙酰氨基酚的五年趋势超出推荐的每日最大剂量
3. Patterns of acetaminophen medication use associated with exceeding the recommended maximum daily dose [J] . Shiffman Saul, Rohay Jeffrey M., Battista Deena, Pharmacoepidemiology and drug safety . 2015,第9期

机译：对乙酰氨基酚药物的使用方式与超过建议的每日最大剂量有关
4. Five‐year trends in acetaminophen use exceeding the recommended daily maximum dose [O] . David W. Kaufman, Judith P. Kelly, Deena R. Battista, 2019

机译：对乙酰氨基酚使用的五年趋势超过建议的每日最大剂量
5. 375 EFFICACY AND SAFETY OF TWICE-DAILY DOSING OF CONTROLLED-RELEASE HYDROCODONE AND ACETAMINOPHEN TABLETS FOR MODERATE TO SEVERE OSTEOARTHRITIS PAIN: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-COONTROLLED STUDY [O] . Gilderman L., Box J., Rankin B., 2007

机译：375次中度至重度骨关节炎疼痛的可控释氢可酮和醋胺酮片剂两次剂量的安全性和安全性：第2阶段，随机，双盲，局部麻醉研究

A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008–2013)

著录项

引文网络

相似文献

相关主题

期刊订阅